From 11th to 14th November 2024, the 56th MEDICA, which attracted global attention,was held as scheduled in Düsseldorf, Germany. As the world's largest and most professional medical equipment exhibition, MEDICA gathered the top medical technology and innovations from all over the world. Biotest made a wonderful appearance at the exhibition with careful preparation and finished the annual exhibition perfectly.

Product Innovation, Technology Leadership

  Biotest always focuses on the innovation of diagnostic products and testing technology. In this exhibition, Biotest launched FluidicNow^TM Microfluidic Immunoassay System, as the 3rd generation of rapid detection technology, its integrated biochip design with active instrumentation system not only improves the sensitivity and speed of detection, but also realizes multi-item joint detection, which demonstrates great advantages in terms of convenience, accuracy, and reagent diversification. In terms of convenience, accuracy, reagent diversity and so on, it shows great advantages. In addition, Biotest also proudly launched the new respiratory 4 in 1 antigen rapid test kit. This product has gained the attention and favour of many customers for its excellent performance and novel and original design. In addition, the company's DiagPal^TM series of immunochromatographic readers, the new beverage drug test kit and the new drug abuse saliva test and many other innovative products were also presented at the booth.

Increase in Certification, New Strategy

  Biotest has increased its product registration and certification to accelerate its market strategy. During the exhibition, Biotest focused on the promotion of 72 products that have obtained CE IVDR certification, and received positive market feedback. At the same time, we also had in-depth communication with customers and professionals on site, exchanged experiences on EU CE and US FDA registration, and collected many valuable suggestions on new product development in different markets. We will develop new and diversified market and product strategies according to the medical diagnostic needs of different countries and regions.

 

Global Vision, Co-operation Forward

  In this era of global innovation, communication and cooperation, Biotest's internationalisation pace is also getting faster and faster. Taking this exhibition as a new starting point, the company will continue to focus on product development and deepen international cooperation, further develop and consolidate its position in the European and American markets, and gradually expand to other regions of the world. With the successful conclusion of MEDICA, we are looking forward to inviting you to MEDLAB in Dubai next year to witness more exciting moments together.